• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠肝细胞癌中的腺相关病毒载体整合位点

AAV vector integration sites in mouse hepatocellular carcinoma.

作者信息

Donsante Anthony, Miller Daniel G, Li Yi, Vogler Carole, Brunt Elizabeth M, Russell David W, Sands Mark S

机构信息

Department of Internal Medicine, Washington University School of Medicine, Box 8007, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

出版信息

Science. 2007 Jul 27;317(5837):477. doi: 10.1126/science.1142658.

DOI:10.1126/science.1142658
PMID:17656716
Abstract

Adeno-associated viruses (AAV) are promising gene therapy vectors that have little or no acute toxicity. We show that normal mice and mice with mucopolysaccharidosis VII (MPS VII) develop hepatocellular carcinoma (HCC) after neonatal injection of an AAV vector expressing b-glucuronidase. AAV proviruses were isolated from four tumors and were all located within a 6-kilobase region of chromosome 12. This locus encodes several imprinted transcripts, small nucleolar RNAs (snoRNAs), and microRNAs. Transcripts from adjacent genes encoding snoRNAs and microRNAs were overexpressed in tumors. Our findings implicate this locus in the development of HCC and raise concerns over the clinical use of AAV vectors.

摘要

腺相关病毒(AAV)是很有前景的基因治疗载体,几乎没有急性毒性或完全没有急性毒性。我们发现,正常小鼠和患有黏多糖贮积症VII型(MPS VII)的小鼠在新生期注射表达β-葡萄糖醛酸酶的AAV载体后会发生肝细胞癌(HCC)。从四个肿瘤中分离出AAV前病毒,它们都位于12号染色体的一个6千碱基区域内。该位点编码几种印记转录本、小核仁RNA(snoRNA)和微小RNA。编码snoRNA和微小RNA的相邻基因的转录本在肿瘤中过度表达。我们的研究结果表明该位点与HCC的发生有关,并引发了对AAV载体临床应用的担忧。

相似文献

1
AAV vector integration sites in mouse hepatocellular carcinoma.小鼠肝细胞癌中的腺相关病毒载体整合位点
Science. 2007 Jul 27;317(5837):477. doi: 10.1126/science.1142658.
2
Assessing the potential for AAV vector genotoxicity in a murine model.评估 AAV 载体在小鼠模型中的潜在遗传毒性。
Blood. 2011 Mar 24;117(12):3311-9. doi: 10.1182/blood-2010-08-302729. Epub 2010 Nov 24.
3
Adeno-associated virus vector integration junctions.腺相关病毒载体整合连接点。
J Virol. 1997 Nov;71(11):8429-36. doi: 10.1128/JVI.71.11.8429-8436.1997.
4
Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.载体设计影响腺相关病毒基因治疗后的肝脏遗传毒性。
J Clin Invest. 2015 Feb;125(2):870-80. doi: 10.1172/JCI79213. Epub 2015 Jan 20.
5
Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.腺相关病毒(AAV)作为基因治疗剂在肝细胞癌中的最新进展。
Virol J. 2024 Jan 12;21(1):17. doi: 10.1186/s12985-024-02286-1.
6
Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction.腺相关病毒重组体在精氨酸转氨甲酰酶基因矫正后的鼠肝中的整合部位。
Hum Gene Ther. 2013 May;24(5):520-5. doi: 10.1089/hum.2012.112.
7
Adeno-associated virus finds its disease.腺相关病毒引发了相应疾病。
Nat Genet. 2015 Oct;47(10):1104-5. doi: 10.1038/ng.3407.
8
Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro.细胞重组途径和病毒末端重复发夹结构足以实现腺相关病毒在体内和体外的整合。
J Virol. 1997 Dec;71(12):9231-47. doi: 10.1128/JVI.71.12.9231-9247.1997.
9
Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.与遗传毒性小鼠模型中致癌事件相关的 scAAV 载体插入模式。
Mol Ther. 2012 Nov;20(11):2098-110. doi: 10.1038/mt.2012.197. Epub 2012 Sep 18.
10
Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents.利用重组腺相关病毒(rAAV)转导肝细胞癌(HCC):遗传毒性剂的体外和体内效应
J Hepatol. 2000 Jun;32(6):975-85. doi: 10.1016/s0168-8278(00)80102-6.

引用本文的文献

1
Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets.神经元蜡样脂褐质沉积症:潜在机制与新兴治疗靶点
Nat Rev Neurol. 2025 Sep 4. doi: 10.1038/s41582-025-01132-4.
2
production of CAR T cell: Opportunities and challenges.嵌合抗原受体T细胞的生产:机遇与挑战。
Genes Dis. 2025 Mar 25;12(6):101612. doi: 10.1016/j.gendis.2025.101612. eCollection 2025 Nov.
3
Gene therapy ameliorates neuromuscular pathology in CLN3 disease.基因疗法改善了CLN3病中的神经肌肉病理状况。
Acta Neuropathol Commun. 2025 Jul 23;13(1):160. doi: 10.1186/s40478-025-02059-z.
4
Structural basis of liver de-targeting and neuronal tropism of CNS-targeted AAV capsids.中枢神经系统靶向性腺相关病毒衣壳的肝脏脱靶和神经元嗜性的结构基础。
bioRxiv. 2025 Jun 3:2025.06.02.655683. doi: 10.1101/2025.06.02.655683.
5
Advances in viral vector-based delivery systems for gene therapy: a comprehensive review.基于病毒载体的基因治疗递送系统的进展:全面综述。
3 Biotech. 2025 Jul;15(7):196. doi: 10.1007/s13205-025-04366-7. Epub 2025 May 30.
6
GSTM1 suppresses cardiac fibrosis post-myocardial infarction through inhibiting lipid peroxidation and ferroptosis.谷胱甘肽S-转移酶M1通过抑制脂质过氧化和铁死亡来抑制心肌梗死后的心脏纤维化。
Mil Med Res. 2025 May 31;12(1):26. doi: 10.1186/s40779-025-00610-6.
7
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type I.CRISPR/Cas9基因疗法增加了I型遗传性酪氨酸血症小鼠模型中肿瘤发生的风险。
JHEP Rep. 2025 Jan 11;7(4):101327. doi: 10.1016/j.jhepr.2025.101327. eCollection 2025 Apr.
8
Gene regulation technologies for gene and cell therapy.用于基因和细胞治疗的基因调控技术。
Mol Ther. 2025 May 7;33(5):2104-2122. doi: 10.1016/j.ymthe.2025.04.004. Epub 2025 Apr 6.
9
The deLIVERed promises of gene therapy: Past, present, and future of liver-directed gene therapy.基因治疗的兑现承诺:肝脏定向基因治疗的过去、现在与未来
Mol Ther. 2025 May 7;33(5):1966-1987. doi: 10.1016/j.ymthe.2025.03.041. Epub 2025 Mar 27.
10
Current advances and future prospects of cell reprogramming in progeroid syndromes.早衰综合征中细胞重编程的当前进展与未来前景
Front Cell Dev Biol. 2025 Feb 19;13:1546423. doi: 10.3389/fcell.2025.1546423. eCollection 2025.